In conclusion, IL-10 levels ≥30 mg/mL increase the ability to identify salvageable brain tissue in patients with CDM and PDM and facilitates the selection of ischemic stroke patients for systemic thrombolysis. Here, IL10 is linked to ischemic stroke.